Alpha DNA Investment Management’s HashiCorp, Inc. Class A Common Stock HCP Stock Holding History

Alpha DNA Investment Management’s Portfolio HCP Stock Details HCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,923	Closed	-$1.11M	–	222
2023 Q1	$1.11M	Sell	37,923 -3,215	-8%	-$96K	0.33%	74
2022 Q4	$1.12M	Buy	41,138 +23,819	+138%	+$674K	0.4%	65
2022 Q3	$557K	Sell	17,319 -13,960	-45%	-$482K	0.46%	97
2022 Q2	$920K	Buy	+31,279	New	+$1.26M	0.78%	90

Other funds holding HCP

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IVMX

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alpha DNA Investment Management's HCP Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of HashiCorp, Inc. Class A Common Stock (HCP) in Q2 2023, closing a stake of 37,923 shares — an estimated $1.11M sold.

Alpha DNA Investment Management first reported a position in HCP in Q2 2022 and held it in 4 quarters. The position peaked at $1.12M in Q4 2022. 211 funds tracked by Wall St. Rank hold HCP as of Q2 2023.

Alpha DNA Investment Management reported no remaining HashiCorp, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 37,923 HashiCorp, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.11M.
Alpha DNA Investment Management first reported a position in HashiCorp, Inc. Class A Common Stock in Q2 2022 and held it in 4 quarters.
Alpha DNA Investment Management's HashiCorp, Inc. Class A Common Stock position peaked at $1.12M in Q4 2022.
211 funds tracked by Wall St. Rank held HashiCorp, Inc. Class A Common Stock as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.